Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SK LIFE

  • FDA Approval
  • Jan. 29, 2024, 15:57 UTC
  • 41
  • 0 comments

FDA approve CENOBAMATE

Comment Full text

CHENGDU

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 36
  • 0 comments

FDA approve TACROLIMUS

Comment Full text

AUROLIFE PHARMA LLC

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 40
  • 0 comments

FDA approve AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Comment Full text

ADAPTIS

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 42
  • 0 comments

FDA approve PREGABALIN

Comment Full text

HOSPIRA

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 38
  • 0 comments

FDA approve ALFENTANIL HYDROCHLORIDE

Comment Full text

HOSPIRA

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 38
  • 0 comments

FDA approve SUFENTANIL CITRATE

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 39
  • 0 comments

FDA approve ACETAZOLAMIDE SODIUM

Comment Full text

GLENMARK GENERICS

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 42
  • 0 comments

FDA approve ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Comment Full text

ANI PHARMS

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 40
  • 0 comments

FDA approve CARBOPROST TROMETHAMINE

Comment Full text

BRECKENRIDGE

  • FDA Approval
  • Jan. 29, 2024, 09:47 UTC
  • 38
  • 0 comments

FDA approve OLMESARTAN MEDOXOMIL

Comment Full text
  • Previous
  • 564
  • 565
  • 566
  • 567
  • 568
  • Next

Search

News categories

  • Technical Exchange News(13116)
  • Event(6229)
  • SEC News(328520)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(183608)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin